COPD and Other Stuff

This is a patient-to-patient blog to exchange information and resources...from COPD to Arthritis to Cellulites to Sarcoidosis to Sleep Apnea to RLS to Psoriasis to Support Groups to Caregivers and all points in between.
Subscribe to RSS
This blog is a Kitsap Sun reader blog. The Kitsap Sun neither edits nor previews reader blog posts. Their content is the sole creation and responsibility of the readers who produce them. Reader bloggers are asked to adhere to our reader blog agreement. If you have a concern or would like to start a reader blog of your own, please contact sunnews@kitsapsun.com.

New Inhaler for COPDers – a miracle? PATHOS Study

March 19th, 2013 by Sharon O'Hara

Ask your doctor…and look for a miracle inhaler for some COPDers.  The PATHOS study published in the Journal of Internal Medicine shows that SYMBICORTR TurbuhalerR (budesonide/formoterol) must be some kind of miracle inhaler for chronic obstructive pulmonary disease (COPD) patients. 

Among other advantages, the PATHOS study showed a 26% decrease in exacerbations for moderate – severe COPD!  The Symbicort    SYMBICORTR TurbuhalerR            inhaler has to be bliss for those COPDers able to use it.   

I’ve used Foradil Aerolizer (Formoterol Fumarate Inhalation Powder) for years.  The Fulmarate ingredient seems to make it a relative of Symbicort        SYMBICORTR TurbuhalerR                and it is the single inhaler I take (of three) that noticeably helps me breathe easier.

Best of all is the promise shown in the PATHOS study:

Dr. Kjell Larsson, Professor of Respiratory Medicine at the Karolinska

Institute in Stockholm said: “So called ‘real world’ studies, such as

PATHOS, together with randomised prospective studies, play an important role

in answering questions about the value of medicines in delivering better,

cost-effective healthcare to patients. These findings can help physicians

and the healthcare community to understand disease patterns and create a

fuller picture of treatment effects and what patients are experiencing.”

The only side-affect/warning I can find  might be for asthma patients.

http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=77788

http://www.4-traders.com/ASTRAZENECA-PLC-4000930/news/AstraZeneca-plc-Real-w

orld-study-comparing-commonly-prescribed-COPD-medicines-shows-choice-of-trea

-16558063/ …thanks to Linda W EFFORTS <www.emphysema.net> 

 

Thanks for listening … Sharon O’Hara < familien1@comcast.net

Spring 2013

p class=”MsoNormal”

Tags: , , , , , , , , , , ,

Email This Post Email This Post Print This Post Print This Post

2 Responses to “New Inhaler for COPDers – a miracle? PATHOS Study”

  1. ArtieB3 Says:

    When I tried Symbicort in the past, it gave me anxiety for days. Even for a couple of days after using it. Now I use Spiriva and Qvar, a inhaler and nebulizer as needed. Maybe I can give this version a try.

  2. Sharon O'Hara Says:

    ArtieB3… I’m also on Spiriva and Qvar inhalers and they’ve worked great for many years. Less so these days. I’m going to ask my pulmo about using the new inhaler.
    Thanks for sharing … Sharon

Leave a Reply

Before you post, please complete the prompt below.

Please enter the word MILK here:

Available on Kindle

About This Blog

This is a patient to patient blog to exchange information and resources...from COPD (Chronic Obstructive Pulmonary Disease) to Arthritis to Cellulites to Sarcoidosis to Sleep Apnea to RLS to Psoriasis to Support Groups to Caregivers and all points in between. Written by Sharon O'Hara.

RSS Subscription

Categories

Archives